Results 301 to 310 of about 399,723 (373)
Effects of plasminogen activator inhibitor-1 deficiency on bone disorders and sarcopenia caused by adenine-induced renal dysfunction in mice. [PDF]
Mizukami Y +6 more
europepmc +1 more source
Treatment using either the thiol isomerase inhibitor isoquercetin or zafirlukast lowers tissue factor levels, decreases VEGF, inhibits PD‐L1, and TMEM176B in a xenograft model of ovarian cancer. A combination of the two agents, at threefold lower concentrations than either drug, significantly enhanced the inhibition further, suggesting a dual action of
Justine A. Keovilay +4 more
wiley +1 more source
A signaling pathway map of plasminogen activator inhibitor-1 (PAI-1/SERPINE-1): a review of an innovative frontier in molecular aging and cellular senescence. [PDF]
Shaikh SB +6 more
europepmc +1 more source
Plasminogen activator inhibitor-1 (PAI-1) [PDF]
openaire +1 more source
Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population. [PDF]
Lomelí-Nieto JA +10 more
europepmc +1 more source
Hemi‐Orolingual Angioedema in a Patient With VEXAS Syndrome
eJHaem, Volume 7, Issue 1, February 2026.
Edwin U. Suárez +2 more
wiley +1 more source
Increased plasminogen activator inhibitor-1 (PAI-1) and its associations with metabolic risk in healthy young adults with early life stress. [PDF]
Kudinova AY +8 more
europepmc +1 more source

